OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
April 02, 2021
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
The innovation of single-use technologies is applicable early on in the manufacturing process.
March 02, 2021
Overcoming time and cost constraints can help enable seed train intensification efforts to maximize product yield.
December 02, 2020
Establishing an automated inline dilution system can potentially ease bottlenecking delays resulting from higher upstream yields.
November 02, 2020
PAT advances are enabling improved process understanding, process control, and error prevention.
October 02, 2020
An innovation such as synthetic biology can develop a consistently stable starting cell line for cell therapy source material.
Bioreactor technology advances can offer seamless manufacturing scale-up and can reduce the timeline and cost of biologics production.
September 16, 2020
The APS system comes equipped with filter switching, liquid management, and cell bleed to reduce risk of human error and increase process robustness.
September 03, 2020
This article will explore the traditional path from the laboratory to the clinic and how the fixed-bed technology provides an alternative solution to meet commercial demands.
August 02, 2020
Process modeling offers an opportunity to troubleshoot for and anticipate difficult aspects of a bioprocess.